The so-called shared epitope (SE) present in HLA-DR molecules predisposes to RA development by preferentially binding autoantigens, thereby leading to the activation of autoreactive CD4+ T cells and the initiation of an autoimmune response (114). The gene discussed is CD4; the disease is rheumatoid arthritis.